Joseph Geraci, CSO/CTO & Co-Founder at NetraMark

Joseph Geraci, CSO/CTO & Co-Founder at NetraMark

From Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere by Julio G. Martinez-Clark

May 15, 2026 · 51 min · Season 2 · Episode 129

About this episode

Dr. Joseph Geraci discusses the impact of artificial intelligence on medicine and clinical research.

In this episode, we sit down with Dr. Joseph Geraci — mathematical physicist, medical scientist, and AI innovator — to explore how artificial intelligence is transforming the future of medicine and clinical research. Dr. Geraci began his career in quantum computing and mathematical physics, earning his PhD under renowned scientist Dr. Daniel Lidar with research supported by DARPA and the U.S. Army’s Disruptive Technology Office. He later expanded his work into artificial intelligence for medi...

People in this episode

Host: Julio G. Martinez-Clark

Guest: Joseph Geraci

Topics covered

  • artificial intelligence
  • medicine
  • clinical research
  • quantum computing
  • mathematical physics

Keywords

  • artificial intelligence
  • clinical research
  • medicine
  • quantum computing
  • mathematical physics

Mentioned in this episode

Organizations: NetraMark, DARPA, U.S. Army’s Disruptive Technology Office

More episodes of Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

Explore listener stats, chart rankings, contacts and more on the Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere podcast page.